Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain

ClinicalTrials.gov ID: NCT00226395

Public ClinicalTrials.gov record NCT00226395. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo- and Active-Control, Single- and Multiple-Dose Evaluation of the Analgesic Efficacy and Safety of Oxymorphone Immediate Release (IR) Tablets in Patients With Moderate/Severe Pain Following Abdominal Surgery

Study identification

NCT ID
NCT00226395
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Endo USA Inc., a Keenova Therapeutics Company
Industry
Enrollment
320 participants

Conditions and interventions

Conditions

Interventions

  • Oxymorphone immediate release Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2004
Primary completion
Not listed
Completion
Jul 31, 2005
Last update posted
Jan 1, 2024

2004 – 2005

United States locations

U.S. sites
21
U.S. states
8
U.S. cities
13
Facility City State ZIP Site status
Brookwood Medical Center Birmingham Alabama 35205
The Medical Center, Dept. Clinical research Birmingham Alabama 35205
Montgomery Women's Health Associates Montgomery Alabama 36113
Arrowhead Community Hospital Phoenix Arizona 85023
John C Lincoln Hospital Phoenix Arizona 85023
Paradise Valley Hospital Phoenix Arizona 85023
Glendale Adventist Medical Center Glendale California 91206
Saddleback Memorial Medical Center Laguna Hills California 92653
Huntington Memorial Hospital Pasadena California 91109
Palm West Hospital Palm Springs Florida 33461
Sacred Heart Hospital Pensacola Florida 32514
Duke University Medical Center Durham North Carolina 27710
Forsyth Medical Center Winston-Salem North Carolina 27103
Medical Park Hospital Winston-Salem North Carolina 27103
Univ. Pittsburgh Hospital Pittsburgh Pennsylvania 15213
Univ. Pittsburgh Medical center Pittsburgh Pennsylvania 15232
Memorial Hermann Memorial City Hospital Houston Texas 77024
The Methodist Hospital Houston Texas 77030
Cottonwood Hospital Salt Lake City Utah 84124
LDS Hospital Salt Lake City Utah 84124
McKay-Dee Hospital Salt Lake City Utah 84124

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00226395, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 1, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00226395 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →